SNIFF POSITION PILLOWS/POPITZ PILLOWS

K023010 · Aeolus International Corporation · MYB · Oct 1, 2002 · Dental

Device Facts

• Record ID: K023010
• Device Name: SNIFF POSITION PILLOWS/POPITZ PILLOWS
• Applicant: Aeolus International Corporation
• Product Code: MYB · Dental
• Decision Date: Oct 1, 2002
• Decision: SESE
• Submission Type: Abbreviated
• Regulation: 21 CFR 872.5570
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Sniff Position Pillows are indicated for the following uses: - 1.) May improve the quality of sleep - 2.) May improve the symptoms of mild obstructive sleep apnea - 3.) May improve snoring

Device Story

Sniff Position Pillows are designed to assist users in maintaining a specific head or neck position during sleep. By promoting a particular posture, the device aims to improve sleep quality, reduce snoring, and alleviate symptoms associated with mild obstructive sleep apnea. The device is intended for over-the-counter use by patients in a home setting. It functions as a physical support pillow; no electronic, algorithmic, or software components are involved in its operation.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Physical pillow device; no electronic components, software, or specific material standards cited. Operates as a mechanical support for head/neck positioning.

Indications for Use

Indicated for individuals seeking to improve sleep quality, reduce snoring, or manage symptoms of mild obstructive sleep apnea.

Regulatory Classification

Identification

Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.

Special Controls

*Classification.* Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white circular logo for the Department of Health & Human Services - USA. The logo features a stylized image of an eagle's head with three profiles overlapping each other. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the top half of the circle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Nov 2 9 2004

Aeolus International Corporation c/o Mike D. Popitz, M.D. President 64 Indian Cove Road Marion, MA 02738

Re: K023010

Trade/Device Name: Sniff Position Pillows/Popitz Pillows Regulation Number: 872.5570 Regulation Name: Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea. Regulatory Class: Class II Product Code: MYB Dated: September 3, 2002 Received: September 9, 2002

Dear Dr. Popitz:

This letter corrects our substantially equivalent letter of October 1, 2002 regarding the Sniff Position Pillows/Popitz Pillows regulatory classification. At the time of that letter, FDA incorrectly classified the Sniff Position Pillows/Popitz Pillows, as indicated, as an unclassified device. This device is classified under 872.5570, Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea. The product code will remain as MYB.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent [{{for the indications for use stated in the enclosure)] to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898.

{1}------------------------------------------------

Page 2 - Mike D. Popitz, M.D.

In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Alberi forental

A. Ralph Rosenthal, M.D. Director Division of Opthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

{2}------------------------------------------------

## Statement of Indications for Use:

The Sniff Position Pillows are indicated for the following uses:

- 1.) May improve the quality of sleep
- 2.) May improve the symptoms of mild obstructive sleep apnea
- 3.) May improve snoring

Karen Abole

on of Ophthalmic

510(k) Number K0223010

Over-the-Counter Use***_***_√